chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Extreme discomfort/pain, body-wide. Sporadic shooting pains at various body points. Fever reached 101.5 before breaking. Head felt as though it was trapped in a vice. Symptoms began easing after approx. 36 hours. Injection site is still very sore.  NOTE: Apparently, some doctors--not mine, unfortunately--suggest taking pain relievers for 36-48 hours prior to receving the vaccine, whihc greatly reduces pain. THIS ADVICE SHOULD BE MANDATORY TO ALL WHO ARE GOING TO RECEIVE THIS VACCINE!
Chills; Fever; Nasal congestion; Headache; Soreness at site of injection; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0186) via an unspecified route of administration in the left arm on 05Aug2021 at 12:45 (at the age of 20-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Aug2021 at 07:00, the patient experienced chills, fever, nasal congestion, headache and soreness at site of injection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, fever, nasal congestion, headache and soreness at site of injection were not resolved at the time of this report.
No adverse reaction. Vaccine administration error. Two doses of Fluad were given. 1st dose was 11/16/2021 and 2nd dose was 01/13/2022.
On day two of receiving shot number 2, my whole body became very achy, as well as a slight headache. I felt very sore, achy and tired for a full day. The next afternoon I discovered a red , inflamed  patch of shingles on right side of my chest.  Then,on August 31, 2021, I again had severe aches, pains across my chest , shoulders,  into my muscles and joints for 2 days now.
Patient awoke morning after flu vaccine with facial swelling, redness of face, hives on forehead and around eyes. She reported tingling of face and lips and her hands were swollen. She was treated with BENADRY and Prednisolone as well as advised to take ZYRTEC daily.
1 week after, site was more tender and sore. The day after that (8 days from initial injection) I woke up to a large, hot red patch over my right upper arm.
Patient reported around 3:15pm that her tongue felt dry, tingly and had metallic taste. She denies trouble breathing.  Gave patient a bottle of water and gave her a dose of Allegra 180 mg which she declined to take but agreed to keep with her. Observed patient over the next 30 minutes and during that time the patient reported a gradual improvement of symptoms.  She spoke on the phone with husband whom is a physican and he told her to drink the water and thought she was fine.  Patient declined EMS and going to the hospital across the street. Upon leaving she states that she is feeling normal and I advised her to call 911/md  if any worsening of symptoms.
Initial unsolicited report received from a consumer (patient's mother) on 26 May 2016. This case involves a 10-year-old female patient who was vaccinated with a first dose of ADACEL (batch number, expiry date, dose, route of administration), in the right deltoid on 25 May 2016. Illness at time of vaccination was reported as none and pre-existing physician diagnosed allergies, birth defects, medical conditions reported as of severe milk, eggs, beef, lamb, and latex. "None". Any other vaccinations within 4 weeks of vaccinations were reported as none. Concomitant medications were not reported. On 25 May 2016, same day "Within 15 minutes" following the vaccination, the patient developed anaphylactic reaction. The patient was consulted with her allergist who confirmed that the vaccine did not contain anything she was allergic to. On an unknown date, the patient was vaccinated with similar vaccines without any incident (when she was a younger child). The patient was transported by ambulance to the Emergency room (for 5 hour). Patient had no laboratory investigation. The patient was treated with EPIPEN (for respiratory treatment), oral BENADRYL and oral steroids (given in ER) and MEDROL dose pack. On an unknown date, the patient was discharged and was recovered from the event. Upon medical review, the case was considered as serious due to important medical event: anaphylactic reaction. List of documents held by sender: none. Sender's Comments: Anaphylactic reaction is listed with DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE. Time to onset is compatible with the role of the vaccine. This case is very poorly documented to assess the role of the vaccine. However, investigation results ruling out a concurrent condition and other etiologies would be helpful to further assess this case.
Flu=like symptoms, body ache, nausea, weakness all over body, no fever back pain led to hospitalization. Blood work, CT scan, and rectal exam, Blood hemoglobin at 6.5. Blood transfusion procedures completed
This spontaneous report as received from a other health professional (registered nurse) refers to unspecified number of patients of unknown age. Current conditions and medical history was not reported. On an unknown date, the unspecified number of patients were vaccinated with VAQTA (dose, route, lot number and frequency were not reported). Concomitant medications were not reported. On an unknown date unspecified number of patients received VAQTA after being improperly stored. No adverse effects reported. Product quality complaint was not reported. This is one of several reports received from the same reporter. Additional information has been requested.
ended up catching covid; ended up catching covid; This is a spontaneous report received from a contactable consumer (patient). A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single; the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 2, single for covid-19 immunisation. The patient medical history was not reported. Concomitant medication included estrogens conjugated (PREMARIN). The patient experienced ended up catching covid on 30Aug2021 even though fully vaccinated. Outcome of the events was unknown.   The lot number for the vaccine BNT162B2, was not provided and will be requested during follow up.
I was treated at the local emergency room Thursday, admitted, and discharged Friday.  They recommended I inform you and my Pulmonologist.   I am home now recovering from a COPD exacerbation that I believe was triggered by the covid vaccine.   Within a couple hours of receiving the vaccine on Wed I started feeling my chest tighten.  I completed my exercise routine on Wed but my results declined from those I achieved the past 3 weeks.  On Thursday I continued to notice the chest tightness but when I tried exercising at 5 PM I had to stop after 1 minute.  After dinner, I began having significant difficulty breathing and the chest tightening increased.  My wife took me to the local Hospital emergency room fearing a heart attack.  Their testing determined it was not a heart attack but a COPD episode.  I was admitted, treated, and discharged Friday afternoon.  Several doctors I reviewed the sequence of events with agreed it was possible the vaccine caused the reaction.  It is Saturday and I am home with prednisone and doxycycline hyclate meds.  My blood pressure and heart rate have improved and are now close to normal.  My oxygen is pretty steady at 91/92 now although I still need to use my combivent inhaler frequently to combat shortness of breath.  This episode is dramatically different than any others I have had in the speed it occurred and symptoms (no coughing or phlegm).  As I said, I believe the trigger was the covid vaccine.
Patient is a 61-year-old female who presents for evaluation of right arm injection site. Patient had hepatitis A vaccination injection and proximal right upper extremity on 10/3/18. Patient reports that 3-4 weeks following injection, she noticed lying of the proximal right upper extremity near injection site. Patient also reported green drainage from the site. Patient denies any drainage since that day. Denies any fever, sweats, chills. Patient reports warmth upon palpating the area on her proximal right upper extremity. Patient also reports pain of the proximal right upper extremity, rating pain 9/10. Denies fever, sweats, chills.
Information has been received from an 83 yr old female with no past medical history and no allergies who on 03Nov04 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Concomitant therapy that day included influenzae virus vaccine (unspecified). On 03Nov04, about three hours after getting injection the pt experienced swollen and red injection site. No medical attention was sought. The pt was considered to be recovering. There were no lab or diagnostic tests performed. No product quality complaint involved. Additional information has been requested.
This is a spontaneous report from a non-contactable physician via a Pfizer colleague. A 18-uyear-old male patient received 2 doses of TRUMENBA at 0.5 ml single dose on unspecified dates. Concomitant medications and medical history were not reported. The patient reported potential side effects like fatigue and nausea after each of the two doses. Outcome was not reported.
MILD NAUSEA; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced mild nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of mild nausea was not reported. This report was non-serious.
This spontaneous report was received from a medical assistant referring to a female patient of unknown age. The patient's medical history, concurrent conditions, concomitant medications, and historical drugs were not reported. On 15-AUG-2009, the patient was vaccinated with GARDASIL fist dose, when she was 10 years old (route, dose, frequency, lot # and expiration date were unknown) for prophylaxis. Subsequently, on 31-JUL-2009, 11 months 17 days after the first dose the patient was vaccinated with the second dose of GARDASIL (route, dose, frequency, lot # and expiration date were unknown) for prophylaxis. The medical assistant stated that the patient at the time of the report was on the office to received the third dose of GARDASIL. Additional information has been requested.
developed 3 blister-like sores on lips (one center lower lip, one near peak of each side of upper lip); cold-like symptoms (congestion); cough; persistent headache; overall feeling run-down; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 14Apr2021 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Concomitant medications included birth control (MANUFACTURER UNKNOWN) and multivitamin (MANUFACTURER UNKNOWN), both taken for unspecified indications from unknown dates. The patient previously took cefaclor (CECLOR) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, approximately 1.5 weeks after the first dose, the patient developed 3 blister-like sores on lips (one center lower lip, one near peak of each side of upper lip) and cold-like symptoms (congestion, cough, persistent headache) and in addition to overall, the patient felt run-down. The clinical outcome of the events blister-like sores on lips, cold-like symptoms (congestion, cough, persistent headache) and felt run-down were unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Tingling on feet. (Left and Right Foot); This spontaneous case was reported by a patient and describes the occurrence of PARAESTHESIA (Tingling on feet. (Left and Right Foot)) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     The patient's past medical history included COVID-19 on 13-May-2022.   On 12-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Jun-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Jun-2022 at 10:00 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PARAESTHESIA (Tingling on feet. (Left and Right Foot)). At the time of the report, PARAESTHESIA (Tingling on feet. (Left and Right Foot)) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-May-2022, SARS-CoV-2 test: positive (Positive) Positive.         No concomitant medications were reported. It was not asked if patient received any vaccine 1 month prior to Moderna COVID-19 vaccine. Batch number was asked but was unknown.  Patient reported that symptom started at around 10 pm and Nurse advised her to go to the Emergency room. No treatment medications were reported.
fevers, sweats, chills, dyspnea with exertion, chest tightness; chest tightness and dyspnea on exertion persisting for 2 weeks. all symptoms began within 12 hours of vaccination. chest tightness primarily with deep breaths.
Headache, Myalgia, CoughWheeze, Syncope,  chest pain  Narrative:  3/12 0830 second dose of COVID-19 Pfizer vaccine. 3/12 1230 onset of headache which is persistent as of 3/19. 3/13 onset of cough, body aches, and chest pain all of which resolved within 2 days. 3/14 onset of diarrhea which  lasted through 3/17. 3/25 - Employee reports headache is better, but still has slight headache in the morning. Her diarrhea resolved as of 3/20.
Maculopapular, pruritic rash over neck, shoulders and trunk. Started: 24 hr after vaccine given. For itch (used x 2 days prn) BENADRYL. Mostly resolved and no itch 9 days after vaccine.
Narrative:  patient received 2 doses of Pfizer Vaccine from Medical Center, Vaccination clinic and patient complains since then she is unable to move her left arm and severe pain
Patient stated he felt tired and needed to lay down, so he was assisted to a floor mat per RN. He remained oriented x3, then started feeling better. He sat up, drank water and ate a protein bar.
starting @ MN c/o h/a & febrile to 104.5;3AM 26OCT96 febrile 104.5 w/babbling & uncontrolled jerking motions of hands;mom gave bath & APAP;taking pt to MD in AM advised to inc fluids & APAP & watch child;
pt recv vax 7NOV96 & 8NOV96 pt presented to ER w/a red inflamed rash on upper trunk & neck;pt was given vax even though had a positive titer;
felt terrible and had fevers; diagnosed with COVID; This is a spontaneous report from a contactable consumer (patient's wife). This consumer reported similar events for herself and for her husband. This report is for her husband. A 70-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 23Mar2021 (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date in Mar2021, the patient felt terrible and had fever, and the patient was diagnosed with COVID on 28Mar2021. The second dose is on 13Apr2021. The patient's wife wanted to know how long they should wait to get the second vaccine, considering the COVID diagnosis. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) :PFIZER INC-2021345482 same reporter, vaccine, and event, different patient
The patient received 2 Flu shots  within the same Flu season: 11/08/22 and 11/22/22
The following information was received from a study investigator on 19Feb2019. The subject is a 62 year old 208lb female subject without relevant medical history. She was previously vaccinated with smallpox  vaccine (immunization date not reported). On 09FEB2019 she received a 2.5mcL immunization percutaneously in the left arm with ACAM2000 (lot VV03-013-C expiry date 10FEB2019). On 19FEB2019 subject was seen by staff for day 12 site check subject explained when she was trying to remove band-aid subject scratched her skin multiple times not realizing she had broken the top layer of skin. It was observed 3 different pustule like formations. The subject has possible auto inoculated from the open wounds. The pustules are all 1-2 inches from vaccination site. Subject was provided further site care instructions and site care kit; contains 12 band aids and waterproof band aids. The outcome for the auto-inoculation is not resolved. The Investigator reported the autoinoculation as mild in severity, not serious and related to the ACAM2000.
Resident given Pfizer dose 1 after having received Moderna two dose series in April. Resident remains free from adverse reaction at this time.
Flu shot rec'd at 9:30 am 10/20/08. C/o headache. Lighted headed and dizziness and (L) arm pain. Onset 1245.
Initial misuse report received from a health care professional on 8 January 2014. The patient whose age was under 18 year had received FLUZONE ID which was inappropriate age of vaccine administration. No adverse event was reported. List of documents held by sender: none
BREECH PRESENTATION; MATERNAL EXPOSURE DURING PREGNANCY; MUSCLE PAIN; This solicited pregnancy report received from a patient concerned a 29 year old female. The patient was enrolled in a study. COVID 19 Registry number: C01768). The patient's weight was 58.96 kilograms, and height was not reported. The patient's pre-existing medical conditions included the patient was pregnant at the time of vaccination.  The patient initiated treatment with Covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: 1802072 and expiry: Unknown) dose was not reported, 1 total administered on 09-MAR-2021 for prophylactic vaccination. The patient's concomitant medications included prenatal vitamins (minerals NOS; vitamins NOS). The patient was gravida 1, para 1. The date of the patient's last menstrual period was 22-SEP-2020. On 09-MAR-2021, the patient had maternal exposure during pregnancy. On the same date, the patient had experienced muscle pain. At gestational age of 39 weeks and 3 days, the mother delivered live male neonate by caesarean method of delivery. On an unspecified date, the patient's was in breech presentation and was hospitalized for two days. The patient gave birth to a male baby. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from breech presentation, and the outcome of muscle pain and maternal exposure during pregnancy was not reported. The reporter provided no causality assessment. Company causality between Covid-19 vaccine ad26.cov2.s, and breech presentation, and muscle pain was related, and between covid-19 vaccine ad26.cov2.s, and maternal exposure during pregnancy was not related.  This report was serious (Hospitalization Caused / Prolonged). This parent/child case is linked to 20211106549.  This case was reassessed as serious based on additional information received from patient on 29-JUL-2021, the following information was updated and incorporated into case narrative: Event added (Breech presentation); Seriousness criteria (hospitalization); Pregnancy outcome updated (C-section); Pregnancy details updated; Narrative updated.; Sender's Comments: V1-  Version created for addition of serious event (Breech presentation); Seriousness criteria (hospitalization); Pregnancy outcome updated (C-section); Pregnancy details and narrative.   20210763277 - covid-19 vaccine ad26.cov2.s- maternal exposure during pregnancy. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS   20210763277 - covid-19 vaccine ad26.cov2.s  Breech presentation. This event(s) is considered related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Vaccine exposure during pregnancy; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Kidney transplant. Concurrent medical conditions included Cancer. Concomitant products included TACROLIMUS for an unknown indication.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). At the time of the report, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) outcome was unknown.            No concomitant medication history were reported No treatment medication information were reported
10 hours after receiving dose 2 of Moderna, she experienced severe nausea and vomiting lasting 6 hours. It resolved without treatment.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. The patient's medical history was not reported. On 15-MAR-2018, the patient was vaccinated with an improperly stored ROTATEQ lot # N016457, expiration date 16-DEC-2018, oral for prophylaxis. The vaccine underwent a temperature excursion of 32 to 35 degrees Fahrenheit for 28 hours. There was a previous temperature excursion of 47 to 77 degrees Fahrenheit for 3 hours. Digital data logger was involved. No adverse effects were reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1803USA010708: US-009507513-1803USA008738.